Wells Fargo analyst Elyse Greenspan lowered the firm’s price target on MetLife (MET) to $92 from $96 and keeps an Overweight rating on the shares. The firm notes MetLife traded down on weak forward guidance and not very encouraging LTC commentary.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife Reports Strong Q3 2025 Earnings Growth
- MetLife’s Earnings Call Highlights Strong Growth and Strategic Focus
- M&A News: Brighthouse Stock (BHF) Jumps through the Roof on $4.1B Acquisition Deal
- MetLife’s Strong Earnings and Resilient Business Model Drive Buy Rating
- MetLife price target lowered to $95 from $96 at UBS